Towards Healthcare
Intravascular Lithotripsy (IVL) Market Expands at 15.24% CAGR by 2034

Intravascular Lithotripsy (IVL) Market 2025 Peripheral IVL Systems Dominate as AI and Minimally Invasive Trends Surge

Based on market forecasts, the intravascular lithotripsy (IVL) sector will expand from USD 170 million in 2024 to USD 708.72 million by 2034, experiencing a CAGR of 15.24%. The intravascular lithotripsy (IVL) market is increasing due to it is a significant adjunctive device in the cardiac catheterization laboratory, which is useful for laceration preparation and guidance of optimum percutaneous coronary interventions. North America is the dominant as early adoption of intravascular lithotripsy technology and clinical trial leadership.

  • Insight Code: 5901
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The intravascular lithotripsy (IVL) market is projected to reach USD 708.72 million by 2034, growing at a CAGR of 15.24% from 2024 to 2034.

North America is currently leading the intravascular lithotripsy (IVL) market due to the advanced healthcare infrastructure and increasing healthcare awareness.

The intravascular lithotripsy (IVL) market includes five segments such as by vessel type, by product type, by application, by end user, and by region.

Key trends include the use of IVL to treat challenging calcified lesions with minimal vessel trauma, and advancements in technology like AI and machine learning.

The IVL contributes to maintaining the facilities and natural environment, use and enjoy them during their stay.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.